Incidence of Gram‐negative bacteraemia in sepsis syndrome Implications for immunotherapy

Incidence of Gram‐negative bacteraemia in sepsis syndrome Implications for immunotherapy

Summary The incidence of Gram‐negative bacteraemia in 100 patients with sepsis syndrome receiving antibiotics, and admitted to the Intensive Therapy Unit, was only 12%. If endotoxin antibody is only effective in bacteraemic patients and these results are confirmed, there would be little indication f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anaesthesia 1994-09, Vol.49 (9), p.751-754
Hauptverfasser: WILLATTS, S. M., SPELLER, D. C. E., WINTER, R. J.
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
Adult
Aged
Aged, 80 and over
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Anti-Infective Agents - therapeutic use
bacteraemia
Bacteremia - blood
Bacteremia - epidemiology
Bacteremia - therapy
Biological and medical sciences
Critical Care
Double-Blind Method
Emergency and intensive care: infection, septic shock
endotoxaemia. Complications
Endotoxins - blood
Female
Gram-Negative Bacterial Infections - blood
Gram-Negative Bacterial Infections - epidemiology
Gram-Negative Bacterial Infections - therapy
Humans
Immunotherapy
Incidence
Infection
Intensive care medicine
Male
Medical sciences
Middle Aged
sepsis syndrome. Endotoxin antibody. Intensive care
Systemic Inflammatory Response Syndrome - blood
Systemic Inflammatory Response Syndrome - complications
Taurine - analogs & derivatives
Taurine - therapeutic use
Thiadiazines - therapeutic use
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary The incidence of Gram‐negative bacteraemia in 100 patients with sepsis syndrome receiving antibiotics, and admitted to the Intensive Therapy Unit, was only 12%. If endotoxin antibody is only effective in bacteraemic patients and these results are confirmed, there would be little indication for its use in our Intensive Therapy Unit.
ISSN:0003-2409
1365-2044
DOI:10.1111/j.1365-2044.1994.tb04443.x